According to NIH Guidelines, research that involves the use of recombinant and synthetic nucleic acid molecules (rDNA); microorganisms; biological toxins; bloodborne pathogens; human and nonhuman primate materials; and transgenic plants and animals must be reviewed and approved by the Institutional Biosafety Committee (IBC) prior to the start of a study. Information regarding protocol submission and the review process can be found on the Office of Research Integrity and Compliance website, https://research.uark.edu/units/rscp/biological-safety.php, or by sending an e-mail to the IBC coordinator at ibc@uark.edu.